HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 18,110
-470 (-2.53%)
At close: Oct 22, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 258.27 billion as of October 22, 2026. It is the 20,714th most valuable company in the world and the 686th biggest in South Korea. Its market cap has decreased by 26.89% in one year.
Market Cap
258.27B
Enterprise Value
280.41B
Revenue
124.81B
Global Rank
Country Rank
#686 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 258.27B, an increase of 427.03%. That is a compound annual growth rate of 10.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 258.27B | -31.63% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 388.96B |
| AprilBio | 371.38B |
| Curocell | 363.17B |
| Inventage Lab | 348.66B |
| S.Biomedics | 262.56B |
| IntoCell | 249.51B |
| IMBiologics | 221.06B |
| Genome & Company | 220.70B |